Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000216609 | SCV000271171 | likely benign | not specified | 2015-05-28 | criteria provided, single submitter | clinical testing | c.6325+13G>A in Intron 32 of USH2A: This variant is not expected to have clinica l significance because it is not located within the conserved splice consensus s equence. This variant has been identified in 35/66520 European chromosomes by t he Exome Aggregation Consortium (ExAC, http://exac.broadinstitute.org; dbSNP rs3 68490585). |
Gene |
RCV000216609 | SCV000730472 | likely benign | not specified | 2018-01-18 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Labcorp Genetics |
RCV001487638 | SCV001692133 | likely benign | not provided | 2025-01-13 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV003445709 | SCV004172103 | likely benign | Retinitis pigmentosa 39 | 2023-04-11 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV003445708 | SCV004172104 | likely benign | Usher syndrome type 2A | 2023-04-11 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV001487638 | SCV005263700 | likely benign | not provided | criteria provided, single submitter | not provided |